This article is part of the supplement: Current perspectives on the treatment of rheumatic diseases with infliximab
Autoantibodies in rheumatoid arthritis and their clinical significance
-
* Corresponding author: Günter Steiner Guenter.Steiner@akh-wien.ac.at
Arthritis Res 2002, 4(Suppl 2):S1-S5 doi:10.1186/ar551
Accesses
- Last 30 days: 142 accesses
- Last 365 days: 1335 accesses
- All time: 11218 accesses
Cited by
BioMed Central: 4 citations
|
Ioannis Alexiou, Anastasios Germenis, Athanasios Ziogas, Katerina Theodoridou, Lazaros I Sakkas BMC Musculoskeletal Disorders 2007, 8:37 (20 April 2007) |
|
The role of the complement and the FcγR system in the pathogenesis of arthritis Samuel Solomon, Daniela Kassahn, Harald Illges Arthritis Research & Therapy 2005, 7:129-135 (16 May 2005) |
|
Karin Lundberg, Suzanne Nijenhuis, Erik R Vossenaar, Karin Palmblad, Walter J van Venrooij, Lars Klareskog, AJW Zendman, Helena Harris Arthritis Research & Therapy 2005, 7:R458-R467 (21 February 2005) |
|
Thomas Pap Arthritis Res Ther 2005, 7:44-46 (20 December 2004) |